ChemComm
Communication
Notes and references
1 K. Kim, Y. Guo and G. A. Sulikowski, J. Org. Chem., 1995, 60,
6866–6871.
2 R. Caple, G. M. S. Chen and J. D. Nelson, J. Org. Chem., 1971, 36,
2874–2876.
3 M. Lautens, Synlett, 1993, 177–185.
4 C. G. Bates, R. K. Gujadhur and D. Venkataraman, Org. Lett., 2002, 4,
2803–2806.
Scheme 2 Iridium-catalyzed asymmetric ring-opening of N-phenylpiperazine
to aza-benzonorbornadiene.
5 M. Lautens, K. Fagnou and M. Taylor, Org. Lett., 2000, 2,
1677–1679.
6 (a) M. Lautens, C. Dockendorff, K. Fagnou and A. Malicki, Org. Lett.,
2002, 4, 1311–1314; (b) M. Murakami and H. Igawa, Chem. Commun.,
2002, 390–391.
7 (a) M. Lautens, S. Hiebert and J.-L. Renaud, Org. Lett., 2000, 2,
1971–1973; (b) M. Lautens, J.-L. Renaud and S. Hiebert, J. Am. Chem.
Soc., 2000, 122, 1804–1805.
8 M. Lautens and K. Fagnou, Tetrahedron, 2001, 57, 5067–5072.
9 P. Leong and M. Lautens, J. Org. Chem., 2004, 69, 2194–2196.
10 (a) M. Lautens, K. Fagnou and D.-Q. Yang, J. Am. Chem. Soc., 2003,
125, 14884–14892; (b) Y.-H. Long, S.-Q. Zhao, H.-P. Zeng and
D.-Q. Yang, Catal. Lett., 2010, 138, 124–133; (c) R. Webster,
A. Boyer, M. J. Fleming and M. Lautens, Org. Lett., 2010, 12,
5418–5421; (d) A. Boyer and M. Lautens, Angew. Chem., Int. Ed.,
2011, 50, 7346–7349; (e) T. D. Nguyen, R. Webster and M. Lautens,
Org. Lett., 2011, 13, 1370–1373.
Scheme 3 The proposed mechanism of the Ir-L1 catalyzed ring-opening of
¨
11 R. Webster, C. Boing and M. Lautens, J. Am. Chem. Soc., 2009, 131,
44–45.
oxabenzonorbornadiene with amines.
12 (a) F. Bertozzi, M. Pineschi, F. Macchia, L. A. Arnold, A. J. Minnaard
´
and B. L. Feringa, Org. Lett., 2002, 4, 2703–2705; (b) R. G. Arrayas,
S. Cabrera and J. C. Carretero, Org. Lett., 2003, 5, 1333–1336;
Encouraged by the good results of the iridium-catalyzed
ring-opening reaction of oxabenzonorbornadiene, the ring-
opening reaction of aza-benzonorbornadiene 8 with N-phenyl-
piperazine was also tested under the above optimized reaction
conditions. Unfortunately, only low yield and enantioselectivity
were obtained (Scheme 2). Further studies are in progress in
our group.
´
(c) F. Lopez, S. R. Harutyunyan, A. J. Minnaard and B. L. Feringa,
J. Am. Chem. Soc., 2004, 126, 12784–12785; (d) K. Tissot-Croset,
D. Polet and A. Alexakis, Angew. Chem., Int. Ed., 2004, 43,
2426–2428; (e) C. A. Falciola, K. Tissot-Croset and A. Alexakis, Angew.
´
Chem., Int. Ed., 2006, 45, 5995–5998; ( f ) F. Lopez, A. W. van Zijl,
A. J. Minnaard and B. L. Feringa, Chem. Commun., 2006, 409–411.
13 (a) M. Lautens and C. Dockendorff, Org. Lett., 2003, 5, 3695–3698;
(b) M. Li, X.-X. Yan, W. Hong, X.-Z. Zhu, B.-X. Cao, J. Sun and
´
X.-L. Hou, Org. Lett., 2004, 6, 2833–2835; (c) S. Cabrera, R. G. Arrayas
and J. C. Carretero, Angew. Chem., 2004, 116, 4034–4037;
(d) C.-L. Chen and S. F. Martin, Org. Lett., 2004, 6, 3581–3584;
(e) T. Imamoto, Y. Saitoh, A. Koide, T. Ogura and K. Yoshida, Angew.
Chem., 2007, 119, 8790–8793; ( f ) T.-K. Zhang, D.-L. Mo, L.-X. Dai
and X.-L. Hou, Org. Lett., 2008, 10, 3689–3692.
A proposed mechanism for this Ir(I)-catalyzed transforma-
tion is illustrated in Scheme 3. When [Ir(coe)2Cl]2 was used as
the iridium source, the dimeric complex was dissociated to
form the corresponding monomer by solvent. And then the
possible catalytic asymmetric ring-opening cycle with amines
may go through four main steps:10a,b,17a,b (a) the monomer
iridium catalyst complexed with oxabenzonorbornadiene; (b)
oxidative insertion to produce the iridium alkoxide; (c) proto-
nation of the iridium alkoxide; (d) nucleophilic attack and
regeneration of the monomer iridium(I) species B. This stereo-
chemical model is in accordance with the absolute configu-
ration observed in the ring-opening product 5ae.21
In summary, we have disclosed an efficient method for Ir–L1
catalyzed ring-opening of oxabenzonorbornadiene with amines,
leading to the formation of a series of substituted dihydro-
naphthalenes in high yields and excellent enantioselectivities.
The new monophosphorus ligand L1 with a big steric chiral
phosphine center is the key to the success of this asymmetric
transformation.
14 M. Nakamura, K. Matsuo, T. Inoue and E. Nakamura, Org. Lett.,
2003, 5, 1373–1375.
15 (a) M. Lautens, P. Chiu, S. Ma and T. Rovis, J. Am. Chem. Soc., 1995,
117, 532–533; (b) M. Lautens and S. Ma, J. Org. Chem., 1996, 61,
7246–7247; (c) M. Lautens and T. Rovis, J. Org. Chem., 1997, 62,
5246–5247; (d) D. K. Rayabarapu and C.-H. Cheng, Chem.–Eur. J.,
2003, 9, 3164–3169.
16 (a) D.-Q. Yang, Y.-H. Long, H. Wang and Z.-M. Zhang, Org. Lett.,
2008, 10, 4723–4726; (b) Y.-H. Long, D.-Q. Yang, Z.-M. Zhang,
Y.-J. Wu, H.-P. Zeng and Y. Chen, J. Org. Chem., 2010, 75, 7291–7299;
(c) S. Fang, X.-L. Liang, Y.-H. Long, X.-L. Li, D.-Q. Yang, S.-Y. Wang and
C.-R. Li, Organometallics, 2012, 31, 3113–3118.
17 (a) D.-Q. Yang, P. Hu, Y.-H. Long, Y.-J. Wu, H.-P. Zeng, H. Wang and
X.-J. Zuo, Beilstein J. Org. Chem., 2009, 5, 53–62; (b) D.-Q. Yang,
Y.-H. Long, J.-F. Zhang, H.-P. Zeng, S.-Y. Wang and C.-R. Li, Orga-
nometallics, 2010, 29, 3477–3480; (c) H.-C. Cheng and D.-Q. Yang,
J. Org. Chem., 2012, 77, 9756–9765; (d) S. Li, H. Chen, Q. Yang, L. Yu,
C. Fan, Y. Zhou, J. Wang and B. Fan, Asian J. Org. Chem., 2013, 2,
494–497.
18 W. Tang, N. D. Patel, G. Xu, X. Xu, J. Savoie, S. Ma, M.-H. Hao,
S. Keshipeddy, A. G. Capacci, X. Wei, Y. Zhang, J. J. Gao, W. Li,
S. Rodriguez, B. Z. Lu, N. K. Yee and C. H. Senanayake, Org. Lett.,
2012, 14, 2258–2261.
19 K. Li, N.-F. Hu, R.-S. Luo, W.-C. Yuan and W. Tang, J. Org. Chem.,
2013, 78, 6350–6355.
We are grateful to the start Fund of School of Pharma-
ceutical Sciences, Gannan Medical University, NSFC-21272254,
STCSM-13PJ1410900, the ‘‘Thousand Plan’’ Youth program, the
Innovation Fund of State Key Laboratory of Bioorganic and
Natural Products Chemistry, and Boehringer Ingelheim.
20 M. Lautens and K. Fagnou, J. Am. Chem. Soc., 2001, 123, 7170–7171.
21 CCDC 943665 (5ae)†.
c
This journal is The Royal Society of Chemistry 2013
Chem. Commun., 2013, 49, 9959--9961 9961